Drug provides health benefits to diabetics with kidney disease
Friday, April 11, 2014 - 15:20
in Health & Medicine
Low doses of atrasentan, an endothelin receptor A inhibitor, lowered urinary protein excretion by 36% in patients with diabetes and kidney disease in a new study. Atrasentan also lowered blood pressure and cholesterol levels without causing major side effects.